3TakahashiA, KonoK, Ichihara F. et al. Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopoplysaccharide, hut not by proinflanmatnry cytokines[J]. Cancer Immunol Immunother. 2004, 53(6) :543-550.
4Streeter E H. Harris A L. Angiogenesis in bladder cancer-prognostic marker and target for future therapy [J]. Surg Oncol.2002,6(11): 85-100.
5Chordhury B A, Liang J C, Thomas E K. et al. Den dritic cells derived in vitro fromacute myelogenous leukemia cellsstimulate autologous antileukemic T-cellresponse [J]. Blood,1999, 93:780.
6Troy A J, Davidson P J, Atkinson C H, et al. CD1 adendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated[J]. Urol, 1999, 161(6): 1962-1967.
7Laxmanan S, Robertson S W, Wang E, et al. Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways [J]. Biochem Biophys Res Commun,2005,334(1): 193-198.
8Gabrilovich D, Ishida T, Oyama T, et al. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo [J]. Blood, 1998, 92(11): 4150-4166.
9Fricke I, Mirza N, Dupont J, et al. Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses[J]. Clin Cancer Res, 2007, 13(16): 4840-4848.
10Saint F,Patard J,Groux Muscatelli B, et al. Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guerin treatment [J]. BJUInt, 2001, 88(6):602-610.
